0000914190-19-000330.txt : 20190821
0000914190-19-000330.hdr.sgml : 20190821
20190821163343
ACCESSION NUMBER: 0000914190-19-000330
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190819
FILED AS OF DATE: 20190821
DATE AS OF CHANGE: 20190821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hippel James
CENTRAL INDEX KEY: 0001603594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 191043376
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-08-19
0000842023
BIO-TECHNE Corp
TECH
0001603594
Hippel James
614 MCKINLEY PLACE N.E.
MINNEAPOLIS
MN
55413
0
1
0
0
Chief Financial Officer
Common Stock
2019-08-19
4
M
0
4925
A
9307
D
Common Stock
2019-08-19
4
F
0
2424
197.57
D
6883
D
Stock Options (Right to Buy)
94.35
2021-08-12
Common Stock
35000
35000
D
Stock Options (Right to Buy)
108.49
2022-08-07
Common Stock
25000
25000
D
Restricted Stock Units
2019-08-19
4
M
0
4925
0
D
Common Stock
4925
0
D
Stock Options (Right to Buy)
106.59
2023-08-18
Common Stock
30400
30400
D
Stock Options (Right to Buy)
106.59
2023-08-18
Common Stock
40533
40533
D
Restricted Stock Units
Common Stock
4438
4438
D
Stock Options (Right to Buy)
125.05
2024-08-09
Common Stock
24460
24460
D
Stock Options (Right to Buy)
125.05
2024-08-09
Common Stock
32613
32613
D
Restricted Stock Units
Common Stock
3383
3383
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
18066
18066
D
Stock Options (Right to Buy)
177.32
2025-08-08
Common Stock
24089
24089
D
Restricted Stock Units
Common Stock
3938
3938
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
19936
19936
D
Stock Options (Right to Buy)
190.41
2026-08-07
Common Stock
26581
26581
D
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
Fully exercisable.
On 8/19/2019, the Board of Directors certified vesting of 4,925 performance RSUs.
Options to purchase 10,134 shares vest on 8/18/2017 and options to purchase 10,133 shares vest on each of 8/18/2018, 8/18/2019 and 8/18/2020.
Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 8,153 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and options to purchase 8,154 shares vest on 8/9/2021.
Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 6,023 shares vest on 8/8/2019 and options to purchase 6,022 shares vest on each of 8/8/2020, 8/8/2021 and 8/8/2022.
Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 6,646 shares vest on 8/7/2020 and options to purchase 6,645 shares vest on each of 8/7/2021, 8/7/2022 and 8/7/2023.
/s/ Brenda S. Furlow, Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed.
2019-08-21